| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282958 | Clinical Gastroenterology and Hepatology | 2012 | 9 Pages |
Abstract
PPI therapy is associated with a 2-fold increase in risk for CDI. Because of the observational nature of the analyzed studies, we were not able to study the causes of this association. Further studies are needed to determine the mechanisms by which PPI therapy might increase risk for CDI.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Abhishek Deshpande, Chaitanya Pant, Vinay Pasupuleti, David D.K. Rolston, Anil Jain, Narayan Deshpande, Priyaleela Thota, Thomas J. Sferra, Adrian V. Hernandez,